Tocilizumab - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector
AUST R: 296808
Active ingredients:
Tocilizumab

Dosage form:
Injection, solution

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

From
01 Sep 2021
to
31 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
Limited stock available. Please contact your wholesaler for information on availability and how to place an order. Instructions for pharmacies is available in the following link: https://www.tga.gov.au/sites/default/files/acetemra-shortage-instructions-for-pharmacies.pdf

A Serious Scarcity Substitution Instrument for Tocilizumab has been implemented. Further information is at: Tocilizumab (Actemra) Serious Scarcity Substitution Instrument | Therapeutic Goods Administration (TGA)
A TGA webstatement is available at https://www.tga.gov.au/alert/shortages-tocilizumab-actemra-medicines
Further information is available at the Roche Australia website by clicking on Actemra in the following link: https://www.roche-australia.com/en_au/products/pharmaceuticals.html

ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe
AUST R: 234034
Active ingredients:
Tocilizumab

Dosage form:
Injection, solution

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

From
16 Aug 2021
to
31 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
Limited stock available. Please contact your wholesaler for information on availability and how to place an order. Instructions for pharmacies is available in the following link: https://www.tga.gov.au/sites/default/files/acetemra-shortage-instructions-for-pharmacies.pdf

A Serious Scarcity Substitution Instrument for Tocilizumab has been implemented. Further information is at: Tocilizumab (Actemra) Serious Scarcity Substitution Instrument | Therapeutic Goods Administration (TGA)
A TGA webstatement is available at https://www.tga.gov.au/alert/shortages-tocilizumab-actemra-medicines
Further information is available at the Roche Australia website by clicking on Actemra in the following link: https://www.roche-australia.com/en_au/products/pharmaceuticals.html

ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
AUST R: 149404
Active ingredients:
Tocilizumab

Dosage form:
Injection, concentrated

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

From
05 Jul 2021
to
31 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
A TGA webstatement is available at https://www.tga.gov.au/alert/shortages-tocilizumab-actemra-medicines
Further information is available at the Roche Australia website by clicking on Actemra in the following link: https://www.roche-australia.com/en_au/products/pharmaceuticals.html

ACTEMRA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
AUST R: 149402
Active ingredients:
Tocilizumab

Dosage form:
Injection, concentrated

Sponsor:
Roche Products Pty Ltd

Phone:
02 9454 9000

From
01 Aug 2021
to
31 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
A TGA webstatement is available at https://www.tga.gov.au/alert/shortages-tocilizumab-actemra-medicines
Further information is available at the Roche Australia website by clicking on Actemra in the following link: https://www.roche-australia.com/en_au/products/pharmaceuticals.html

ACTEMRA tocilizumab (rch) 80 mg/4 mL injection concentrated vial
AUST R: 149403
Active ingredients:
Tocilizumab

Dosage form:
Injection, concentrated

Sponsor:
Roche Products Pty Ltd

Phone:
1800 233 950

From
16 Aug 2021
to
31 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
A TGA webstatement is available at https://www.tga.gov.au/alert/shortages-tocilizumab-actemra-medicines
Further information is available at the Roche Australia website by clicking on Actemra in the following link: https://www.roche-australia.com/en_au/products/pharmaceuticals.html